biomedicina slovenica


re="Cancer" : 601-700

  1. Uršič H; Šalehar A
    Use of alginate dressings in the care of chronic wound
    1999
  2. Bešić N; Auersperg M; Us-Krašovec M; Golouh R; Brecelj E
    Primary treatment and survival in anaplastic thyroid carcinoma
    1999
  3. Novaković Srdjan; Ihan Alojz; Jezeršek Barbara
    Effectiveness of a simply designed tumor vaccine in prevention of malignant melanoma development
    1999
  4. Levičar N; Blejec A; Kos J; Golouh R; Vrhovec I; Frkovič-Gracio S; Lah TT
    Prognostic impact of serine and cysteine proteinases and their inhibitors in breast carcinoma
    1999
  5. Bonnefoi H; Biganzoli L; Čufer T; Hamilton A; Mauriac L; Van Hoorebeeck I; Piccart M
    A feasibility study of epirubicin (E) in combination with cyclophosphamide (C) and infusional 5-fluorouracil (F-infu)(CEF-infu) as primary treatment of large operable (LO) or locally advanced/inflammatory (LA/I) breast cancer (BC)
    1999
  6. Primic-Žakelj Maja
    The association of Slovenian cancer societies
    1999
  7. Alexander FE; Boyle P; Carli P-M; Coebergh JW; Ekbom A; Levi F; McKinney PA; McWhirter W; Michaelis J; Pompe-Kirn V
    Population density and childhood leukemia: results of the EUROCLUS study
    1999
  8. Serša G; Čemažar M; Parkins CS; Chaplin DJ
    Tumour blood flow changes induced by application of electric pulses
    1999
  9. Rakar S; Gergolet M; Kovačič J; Eržen M
    The choice of surgical treatment in endometrial cancer
    1999
  10. Debeljak Andrej; Triller Nadja; Terčelj Marjeta; Kern Izidor; Eržen Janez
    Bronhoscopic needle aspiration (BNA) in the staging of lung cancer
    1997
  11. Kobal B; Rakar S; Ribič-Pucelj M; Tomaževič T; Zaletel-Kragelj L
    Pretreatment evaluation of adnexal tumors predicting ovarian cancer
    1999
  12. Kos Janko; Nielsen Hans-Jorgen; Krašovec Marta; Christensen Ib Jarle; Cimerman Nina; Stephens Ross W; Bruenner Nils
    Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer
    1998
  13. Werle B; Loetterle H; Schanzenbaecher U; Lah TT; Kalman E; Kayser K; Buelzebruck H; Schirren J; Krašovec M; Kos J
    Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients
    1999
  14. Laake Kirsten; Launonen Virpi; Niederacher Dieter; Gudlaugsdottir Sigfridur; Seitz Susanne; Rio Pascale; Champeme Marie-Helene; Bieche Ivan; Sever Nataša; Peterlin Borut; et al ;
    Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study
    1999
  15. Launonen V; Laake K; Huusko P; Niederacher D; Beckmann MW; Barkardottir RB; Geirsdottir EK; Gudmundsson J; Velikonja N; Peterlin B; et al ;
    European multicenter study on LOH of APOC3 at 11q 23 in 766 breast cancer patients: relation to clinical variables. Breast cancer somatic genetics consortium
    1999
  16. Lavrenčak J; Fležar M; Geršak K; Us-Krašovec M
    Image cytometry DNA ploidy of human granulosa cells in follicular fluids from women undergoing in vitro fertilization program
    1998
  17. Goldhirsch Aron; Novak J; Eržen D; Naglas M; Senčar M; Červek J; Cerar O; Štabuc B; Golouh R; Lamovec J; Jančar J; Šebek S; Zakotnik B; Plesničar A; Majdič E; Vrhovec I; Kramberger M; Zidar M; Bračko M
    Present and future projects of the International breast cancer study group
    1994
  18. Pagani O; Eržen D; Cerar O; Štabuc B; Golouh R; Lamovec J; Šebek S; Kramberger M; Vrhovec I; et al ;
    Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer pateints with axillary node involvement: results of the International breast cancer study group (IBCSG) trial VI
    1998
  19. Pinder SE; Lamovec J; Jančar J; Novak J; Eržen D; Naglas M; Senčar M; Červek J; Cerar O; Štabuc B; Šebek S
    The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy
    1998
  20. Pompe-Kirn Vera; Volk Neva; Brus Mojca; Milčič Neža; Robek Nataša; Škrlec Fani
    Slovenia Cancer Registry of Slovenia, 1981-1990
    1998
  21. Zadravec-Zaletel L; Bratanič N; Korenjak R; Macedoni-Lukšič M; Stirn-Kranjc B; Černelč S; Jereb B
    Late sequelae in brain tumor patients treated with central nervous axis irradiation (CNA RT)
    1998
  22. Bobnar A; Piškur J; Slekovec-Kolar B
    Information and truth - a key to the quality of life?
    1998
  23. Kolonić V; Stopar T; Mavrič O
    Treatment of postmastectomy pain syndrome
    1998
  24. Skela-Savič B; Drolc H; Velepič M
    Team approach to the management of nutrition problems in patients receiving chemotherapy
    1998
  25. Čemažar M; Miklavčič D; Ščančar J; Dolžan V; Golouh R; Serša G
    Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin
    1999
  26. Strojnik Tadej; Kos Janko; Židanik Boris; Golouh Rastko; Lah Tamara
    Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors
    1999
  27. Eržen Mojca; Rainer Srečko; Kovačič Jule; Rakar Stelio
    Impact of pathomorphological features on treatment of stage IA cervical carcinoma: 17-year experience
    1998
  28. Rakar S; Kralj B; Eržen M
    Wertheim radical hysterectomy: the Ljubljana experience
    1998
  29. Kralj B; Lukanovič A; Rakar S
    Micturition disturbances and uridynamic changes after radical hysterectomy
    1998
  30. Foekens JA; Kos J; Peters HA; Krašovec M; Look MP; Cimerman N; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten VLJ; Klijn JGM
    Prognostic significance of cathepsin B and L in primary human breast cancer
    1998
  31. Ravnik-Glavač Metka; Mašera Andrej; Ovčak Zdenka; Glavač Damjan
    Methylation of the von Hippel-Lindau (VHL) tumor suppressor gene in renal cell carcinoma (RCC)
    1996
  32. Glavač Damjan; Brauch Hiltrud
    Molecular genetics of the von Hippel-Lindau syndrome
    1996
  33. Komel Radovan
    Oncogenes and tumor suppressor genes
    1996
  34. Boffetta Paolo; Garcia-Gomez Monserrat; Pompe-Kirn Vera; Zaridze David; Bellander Tom; Bulbulyan Mariana; Caballero Jose Diego; Ceccarelli Franco; Colin Didier; Dizdarevič Tatjana; Espanol Santiago; Kobal Alfred
    Cancer occurrence among European mercury miners
    1998
  35. Čufer Tanja
    Adjuvant therapy of breast cancer: update
    1998
  36. Primic-Žakelj Maja
    Screening mammography for early detection of breast cancer
    1998
  37. Jezeršek B; Novakovič S
    The correlation of MCA, CA 15-3 and CEA usefulness in monitoring of breast cancer patients
    1998
  38. Novakovič S; Lavrič M; Jezeršek B
    Gene therapy and immunotherapy
    1998
  39. Lah TT; Levičar N; Kos J; Golouh R; Nils B; Werle B; Ebert W
    Altered expression of stefins, the inhibitors of cysteine cathepsins, are associated with bad prognosis of breast and lung carcinoma
    1998
  40. Alexander FE; Boyle P; Carli P-M; Coebergh JW; Draper GJ; Ekbom A; Levi F; McKinney PA; McWhirter W; Pompe-Kirn V
    Spatial clustering of childhood leukaemia: summary results from the EUROCLUS project
    1998
  41. Serša G; Štabuc B; Čemažar M; Jančar B; Miklavčič D; Rudolf Z
    Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients
    1998
  42. Pinder SE; Murray S; Ellis O; Trihia H; Elston CW; Gelber RD; Goldhirsch A; Lindtner J; Cortes-Funes H; Simoncini E; Byrne MJ; Golouh R
    The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy
    1998
  43. Strojan P; Budihna M; Šmid L; Vrhovec I; Škrk J
    Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients
    1998
  44. Šentjurc Marjeta; Zorec Maša; Čemažar Maja; Auersperg Marija; Serša Gregor
    Effect of vinblastine on cell membrane fluidity in vinblastine-sensitive and -resistant HeLa cells
    1998
  45. Mir LM; Glass LF; Serša G; Teissie J; Domenge C; Miklavčič D; Jaroszeski MJ; Orlowski S; Reintgen DS; Rudolf Z; Belehradek Jr; Bachaud JM; DeConti R; Štabuc B; Čemažar M; Coninx P; Heller R
    Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy
    1998
  46. Škrk J; Čemažar M; Mitrović B; Šorli M; Serša G
    Boron entrapment in B16 melanoma cells and tumors by application of electric pulses
    1998
  47. Rant J; Čemažar M; Byron G; Yanagie H; Škrk J; Kobayashi H; Gabel D; Serša G
    Detection of 10B distributions in histological samples by neutron capture autoradiography using cold neutron beams and photoluminiscent imaging
    1998
  48. Edhemović I; Volk N; Auersperg M
    Second primary cancers following thyroid cancer in Slovenia. A population-based cohort study
    1998
  49. Škrbinc B; Babič A; Us-Krašovec M
    Breast cancer grading in cell samples
    1998
  50. Mir LM; Domenge C; Orlowski S; Bachaud JM; Teissie J; Coninx P; Serša G; Miklavčič D; Glass LF; Jaroszeski MJ; Heller R
    Traitement de tumeurs malignes cutanees et sous-cutanees par electrochimiotherapie
    1998
  51. Zwitter M; Tobias JS
    A survey of the ethical considerations in randomised trials for lung cancer
    1998
  52. Pagani O; O'Neil A; Castiglione M; Gelber RD; Goldhirsch A; Rudenstam C-M; Lindtner J; Collins J; Crivellari D; Coates A
    Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer pateints with axillary node involvement: results of the International breast cancer study group (IBCSG) trial VI
    1998
  53. Vegelj-Pirc M; Zalokar-Divjak Z; Musek J; Purič F
    The meaning of life with women after breast cancer treatment
    1998
  54. Vegelj-Pirc M; Snoj Z
    The influence of the early childhood family climate on later breast cancer morbidity
    1998
  55. Južnič T; Čufer T; Borštnar S
    Male breast cancer: a 20 year review of 60 patients in Slovenia
    1998
  56. Zwitter Matjaž; Čufer Tanja; Smrdel Uroš; Therasse Patrick
    Culture and communication: approach to patients in clinical research
    1998
  57. Lindtner J
    The impact of surgeon's skill on disease free survival of operable breast cancer patients
    1998
  58. Strojan Primož; Budihna Marjan; Šmid Lojze; Vrhovec Ivan; Škrk Janez
    Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck
    1998
  59. Debeljak Andrej; Triller Nadja; Terčelj Marjeta; Kern Izidor; Eržen Janez
    Bronchoscopic needle aspiration (BNA) in the staging of lung cancer
    1997
  60. Jerman J; Sok M
    Is serum cholesterol a prognostik factor in lung cancer patients?
    1997
  61. Družina B; Bukovec P
    Monitoring of content of certain types of carcinogenic substances and pesticides in drinking water in Slovenia and attempts at biodegradation with fermented cereal
    1998
  62. Levičar Nataša; Blejec Andrej; Golouh Rastko; Grazio Snežana; Vrhovec Ivan; Brunner Nils; Kos Janko; Lah Tamara T
    Prognostic relevance of cysteine cathepsins B and L and serine proteases U-PA and their inhibitors, stefins A and B and PAI-1 in breast cancer
    1998
  63. Filipič Metka; Levičar Nataša; Lah Tamara T
    Comparison of different methods for quantifying tumour cell invasion through the artificial basement membrane matrix Matrigel
    1998
  64. Kopitar-Jerala Nataša; Jerala Roman; Gubenšek Franc; Turk Vito
    Anti human stefin A monoclonal antibodies: epitope mapping and expression of recombinant Fab fragments
    1998
  65. Kos Janko; Nielsen Hans-Jorgen; Krašovec Marta; Christensen Ib-Jarle; Cimerman Nina; Stephens Ross W; Turk Vito; Bruenner Nils
    Prognostic relevance of serum cathepsin B and its inhibitors stefins A and B and cystatin C in colorectal cancer
    1998
  66. Čemažar Maja; Miklavčič Damijan; Serša Gregor
    Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy
    1998
  67. Čufer Tanja; Vrhovec Ivan; Pfeifer Marija; Škrk Janez; Borštnar Simona; Sikić Branimir I
    Effect of the multidrug resistance modulator valspodar on serum cortisol levels in rabbits
    1998
  68. Pompe-Kirn Vera
    Slovenia
    1997
  69. Kos J; Krašovec M; Cimerman N; Nielsen HJ; Christensen IJ; Stevens R; Brunner N
    Prognostic value of serum cathepsin B in colon cancer
    1997
  70. Horiot JC; Bontemps P; Begg AC; Le Fur R; van der Bogaert W; Bolla M; Nguyen T; van der Weijngaert D; Bernier J; Jančar B; et al
    New radiotherapy fractionation schemes in head and neck cancers. The EOTC trials: a benchmark
    1997
  71. Štabuc B; Ocvirk J; Plesničar A; Čurin V; Žunec P; Rožman P
    Increased serum levels of soluble receptor for tumours necrosis factor p-55 in melanoma patients
    1997
  72. Lokajner G
    Individual nursing approach for patients with an I.A. hepatic access port
    1997
  73. Volk N; Pompe-Kirn V
    Second primary cancers in breast cancer patients in Slovenia
    1997
  74. Pompe-Kirn Vera
    Cancer registry of Slovenia: 46 years of experience
    1996
  75. Novak-Despot D; Kos J; Serša G; Čemažar M; Škrk J; Gubenšek F
    Boronated CDI 315B monoclonal antibody and its potential use in boron neutron capture therapy
    1997
  76. Serša G; Čemažar M; Novaković S; Rant J; Krištof E; Miklavčič U; Glumac B; Mitrovič B; Škrk J
    Radiation effect of boron neutron capture therapy on mouse melanoma and breast carcinoma cells in vitro
    1997
  77. Bobnar A; Piškur J
    Prevention of extravasation during application of cytostatics via peripheral veins
    1997
  78. Robertson C; Primic-Žakelj M; Boyle P; Hsieh CC
    Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25-54 years
    1997
  79. Strojan P; Debevec M; Kovač V
    Superior sulcus tumor (SST): management at the Institute of oncology in Ljubljana, Slovenia, 1981-1994
    1997
  80. Zwitter M
    Ethical meta-analysis of randomised trials for lung cancer
    1997
  81. Osmak M; Babić D; Abramić M; Vrhovec I; Miličić D; Škrk J
    Cathepsin D content in malignant tumours of corpus uteri
    1997
  82. Omejc M; Repše S; Bračko M
    Evaluation of DNA ploidy in gastric carcinoma
    1997
  83. Repše S; Omejc M; Juvan R; Jelenc F; Lamovec J
    Gastric cancer: 10-year results
    1997
  84. Juvan R; Repše S; Omejc M; Jelenc F; Lamovec J
    Prognostic value of lymph node metastasis ratio in gastric cancer
    1997
  85. Kos Janko; Štabuc Borut; Schweiger Ana; Krašovec Marta; Cimerman Nina; Kopitar-Jerala Nataša; Vrhovec Ivan
    Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
    1997
  86. Rudolf Z; Krošl G; Furlan L; Roš T
    Alpha-leukocyte interferon in malignant melanoma - preliminary results of a randomized study
    1987
  87. Serša G; Čemažar M; Miklavčič D
    Potentiation of CDDP antitumor effectiveness by electric pulses
    1997
  88. Zakotnik Branko
    To tell or not to tell?: communication with cancer patients
    1997
  89. Zwitter Matjaž
    Communication with the patient in clinical research
    1997
  90. Boice JD Jr; Blettner M; Kleinerman RA; Engholm G; Stovall M; Lisco H; Austin DF; Bosch A; Harlan L; Pompe-Kirn V; et al
    Radiation dose and breast cancer risk in patients treated for cancer of the cervix
    1989
  91. Davis BW; Lindtner J; Novak J; Naglas M; Červek J; Vodnik A; Majdič E; Mavec P; Lamovec J; Šebek S; Senčar M; Štabuc B
    Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis
    1986
  92. Serša Gregor; Čemažar Maja; Menart Viktor; Gaberc-Porekar Vladka; Miklavčič Damijan
    Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice
    1997
  93. Brauch Hiltrud; Glavač Damjan; Neumann Hartmut PH
    Germline mutations in the VHL tumor suppressor gene in patients with von Hippel-Lindau disease: correlation with phenotypes and presymptomatic diagnosis
    1996
  94. Devilee P; Hermans J; Eyfjord J; Boorresen AL; Liderau R; Sobol H; Borg A; Cleton-Jansen AM; Olah E; Peterlin B
    Loss of heterozygosity at 7q31 in breast cancer: results from an International collaborative study group
    1997
  95. Kos Janko
    Lysosomal proteases and their inhibitors in malignant progression
    1996
  96. Sloane BF; Rozhin J; Lah TT; Day NA; Buck M; Ryan RE; Crissman JD; Honn KV
    Tumor cathepsin B and its endogenous inhibitors in metastasis
    1988
  97. Werle B; Juelke B; Lah T; Spiess E; Ebert W
    Cathepsin B fraction active at physiological pH of 7,5 is of prognostic significance in squamous cell carcinoma of human lung
    1997
  98. Pompe-Kirn V
    Cancer incidence in Slovenia with emphasis on the elderly
    1992
  99. Plesničar S; Serša G; Krošl G; Novaković S
    The effect of interleukin-2 in combination with dacarbazine on peripheral blood cells in C5781
    1989
  100. Jezeršek B; Červek J; Rudolf Z; Novaković S
    Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients
    1996

   1 101 201 301 401 501 601 701 801  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics